11/17/2026 | Press release | Distributed by Public on 11/18/2026 12:49
Lake Street is pleased to announce that it served as sole bookrunner for Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) in its sale of 8,571,429 shares of common stock (or pre-funded warrants in lieu thereof) in an underwritten public offering at a price per share of $1.75 (or $1.7499 per pre-funded warrant) for gross proceeds of approximately $15.0 million. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes, including but not limited to research and development in the transplantation category.